ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Nymox Pharmaceutical Corp

Nymox Pharmaceutical Corp (NYMX)

0.20
0.00
( 0.00% )
Updated: 20:00:00

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0009k0000
Operating Income -2.8M-5.07M-1.78M-1.48M1.68M-1.39M-1.1M-1.01M
Pre Tax Income -2.81M-5.09M1.34M-1.49M-1.34M-1.39M-1.11M-1.04M
Net Income -2.81M-5.09M1.34M-1.49M-1.34M-1.39M-1.11M-1.04M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -2.8M-5.07M1.33M-1.48M-1.32M-1.39M-1.1M-1.01M
EBITDA -2.79M-5.07M-1.78M-1.48M1.69M-1.38M-987k-973k
Year End December 30 2022 20152016201720182019202020212022
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 2.76M283k224k299k116k5k00
Operating Income -17.66M-12.87M-13.24M-10.64M-13.33M-11.72M-12.5M-6.65M
Pre Tax Income -17.88M-13.11M-13.43M-10.59M-13.16M-11.74M-12.54M-6.58M
Net Income -17.88M-13.11M-13.43M-10.59M-13.16M-11.74M-12.54M-6.58M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.416-0.267-0.238-0.164-0.185-0.151-0.147-0.073
EBIT -17.66M-12.87M-13.24M-10.64M-13.33M-11.72M-12.5M-6.54M
EBITDA -17.66M-12.87M-13.23M-10.64M-13.33M-11.71M-12.49M-6.64M

Your Recent History

Delayed Upgrade Clock